Steven Nissen
Director, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic · Cleveland Clinic Outpatient Center A - Austintown
Credentials: · · · ·
History
- Present
Joseph J. Jacobs Center for Thrombosis and Vascular Biology · Cleveland Clinic Outpatient Center A - Austintown
- Present
Cleveland Clinic Cardiovascular Coordinating Center - an · Cleveland Clinic Outpatient Center A - Austintown
1970–1974
Research
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine · 2016 · 5,696 citations
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Systematic review or meta-analysis · New England Journal of Medicine · 2007 · First of 2 authors · Corresponding · 3,564 citations
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes
New England Journal of Medicine · 2017 · 2,091 citations
- ET
130 papers
- AL
75 papers
71 papers · 30 as a fellow
66 papers · 46 as a fellow
66 papers · 9 as a fellow
36 papers
33 papers
33 papers
Clinical trials
- 2014–2020
Principal investigator · Completed · Phase 3
AstraZeneca
- 2021–2022
- 2017–2019
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Study chair · Terminated · Phase 4
The Cleveland Clinic